The public perception of New York Jets quarterback Aaron Rodgers has flipped from near universal approval ... you’re twice vaxxed Moderna with three booster shots. ... I don’t care.

Over the previous few years, every mRNA-based booster I’d gotten — the ones made by Moderna and Pfizer ... breezy Novavax for me. Still, more than half of Americans don’t plan to get ...

The U.S. feathered its own bed by approving an updated Moderna booster last summer. CEO Stéphane Bancel gave investors a rosy assessment Monday, saying Moderna's R&D investments for the next three ...

The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

Investing.com -- Argus downgraded Moderna Inc (BMV:MRNA) (NASDAQ:MRNA) to "hold" from "buy," on declining sales of its COVID-19 vaccine and limited near-term growth prospects. The brokerage noted ...

Moderna made a lot of money during the pandemic, but its post-pandemic prospects look bleak. Sales in 2025 could be down more than half from 2024 levels, according to Moderna's latest guidance ...

Moderna projects $1.5 billion-$2.5 billion in 2025 revenue, with cash and investments estimated at $6 billion by year-end. 2024 product sales are approximately $3 billion-$3.1 billion, driven by $ ...

Moderna Inc. shares plunged after the company slashed its sales forecast for this year as it struggles with slow demand for its Covid and RSV vaccines. The Cambridge, Massachusetts-based company ...

Moderna stock gained 14%, shooting up to $48.56 per share Tuesday afternoon. Vaccine-makers Novavax and CureVac similarly rose, soaring 15% and 10%, respectively, while Pfizer gained 2% and GSK ...

Moderna's chief executive. He stressed however that the mRNA-1273.214 candidate – which combines the current SpikeVax booster with an Omicron-specific candidate – is the company's lead ...

Moderna’s stock price has dropped about 60% in the past 12 months. Facing this set of challenges, Moderna in September laid out a plan to cut annual R&D spending by more than 20%, or $1.1 ...